BioCentury | Oct 19, 2019
Product Development

Tracking the rise and fall of next-generation checkpoint targets for cancer

...stimulatory checkpoints. Each program is counted only once, with its status reflecting its lead indication. Kitov Pharmaceuticals Holdings Ltd....
...cCAM Compound ”). While no others have been disclosed, CM-24 could be making a comeback. Kitov Pharmaceuticals Holdings Ltd....
...Senior Writer, Research & Analytics Bristol-Myers Squibb Co. Immutep Ltd. Roche Novartis AG GlaxoSmithKline plc AnaptysBio Inc. cCAM Biotherapeutics Ltd. Merck & Co. Inc. Kitov Pharmaceuticals Holdings Ltd. ImmuNext...
BioCentury | Apr 6, 2018
Finance

Smid-cap smorgasbord

...Ph III REACH1 data 2Q18 KemPharm Inc. (NASDAQ:KMPH) KP415 ADHD Final Ph III data Mid-2018 Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...Pharma N.V. (Euronext:KDS) ATIR Transplant-related mortality following hematopoietic stem cell transplant (HSCT) EMA approval 2H18 Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Nov 30, 2017
Clinical News

FDA accepts NDA for Kitov's KIT-302 to treat OA pain and hypertension

...FDA accepted for review an NDA from Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV) for celecoxib/amlodipine besylate (KIT-302) to...
...Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV), Tel Aviv, Israel Product: Celecoxib/amlodipine besylate (KIT-302) Business: Cardiovascular, Neurology Alicia Parker celecoxib/amlodipine besylate KIT-302 Kitov Pharmaceuticals Holdings Ltd. Calcium...
BioCentury | Mar 17, 2017
Company News

Kitov, Kuhnil deal

...to treat hypertension and pain caused by osteoarthritis (OA). Kuhnil did not respond to inquiries. Kitov Pharmaceuticals Holdings Ltd....
...NASDAQ:KTOV), Tel Aviv, Israel Kuhnil Pharmaceutical Co. Ltd. , Seoul, South Korea Business: Cardiovascular, Neurology Chris Lieu Kitov Pharmaceuticals Holdings Ltd. Kuhnil...
BioCentury | Jan 20, 2017
Company News

TyrNovo, Kitov deal

...Israel). TyrNovo Ltd. , Herzliya, Israel Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV), Tel Aviv, Israel Business: Cancer Alicia Parker Kitov Pharmaceuticals Holdings Ltd. TyrNovo...
BioCentury | Jul 25, 2016
Clinical News

Celecoxib/amlodipine besylate: Additional Phase III data

...of celecoxib/amlodipine besylate in parallel with an NDA submission for the product at year end. Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jul 11, 2016
Finance

Ground up

...Date Raised Post-$ 6/30 mcap % chg Tesaro Inc. (NASDAQ:TSRO) 6/30/16 $433.1 $4,146.6 $4,302.7 4% Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jul 11, 2016
Finance

Rethinking risk

...lymphoma (DLBCL), primary mediastinal B cell lymphoma (PMBCL) and transformed follicular lymphoma Submit BLA YE16 Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jul 11, 2016
Financial News

Kitov Pharmaceuticals completes follow-on

Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV), Tel Aviv, Israel Business: Cardiovascular, Neurology Date completed: 2016-06-29 Type: Follow-on Raised: $12 million Units: 2.4 million Price: $3.40 (unit) Shares after offering: 6.5 million Underwriters: H.C. Wainwright;...
Items per page:
1 - 10 of 20
BioCentury | Oct 19, 2019
Product Development

Tracking the rise and fall of next-generation checkpoint targets for cancer

...stimulatory checkpoints. Each program is counted only once, with its status reflecting its lead indication. Kitov Pharmaceuticals Holdings Ltd....
...cCAM Compound ”). While no others have been disclosed, CM-24 could be making a comeback. Kitov Pharmaceuticals Holdings Ltd....
...Senior Writer, Research & Analytics Bristol-Myers Squibb Co. Immutep Ltd. Roche Novartis AG GlaxoSmithKline plc AnaptysBio Inc. cCAM Biotherapeutics Ltd. Merck & Co. Inc. Kitov Pharmaceuticals Holdings Ltd. ImmuNext...
BioCentury | Apr 6, 2018
Finance

Smid-cap smorgasbord

...Ph III REACH1 data 2Q18 KemPharm Inc. (NASDAQ:KMPH) KP415 ADHD Final Ph III data Mid-2018 Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...Pharma N.V. (Euronext:KDS) ATIR Transplant-related mortality following hematopoietic stem cell transplant (HSCT) EMA approval 2H18 Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Nov 30, 2017
Clinical News

FDA accepts NDA for Kitov's KIT-302 to treat OA pain and hypertension

...FDA accepted for review an NDA from Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV) for celecoxib/amlodipine besylate (KIT-302) to...
...Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV), Tel Aviv, Israel Product: Celecoxib/amlodipine besylate (KIT-302) Business: Cardiovascular, Neurology Alicia Parker celecoxib/amlodipine besylate KIT-302 Kitov Pharmaceuticals Holdings Ltd. Calcium...
BioCentury | Mar 17, 2017
Company News

Kitov, Kuhnil deal

...to treat hypertension and pain caused by osteoarthritis (OA). Kuhnil did not respond to inquiries. Kitov Pharmaceuticals Holdings Ltd....
...NASDAQ:KTOV), Tel Aviv, Israel Kuhnil Pharmaceutical Co. Ltd. , Seoul, South Korea Business: Cardiovascular, Neurology Chris Lieu Kitov Pharmaceuticals Holdings Ltd. Kuhnil...
BioCentury | Jan 20, 2017
Company News

TyrNovo, Kitov deal

...Israel). TyrNovo Ltd. , Herzliya, Israel Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV), Tel Aviv, Israel Business: Cancer Alicia Parker Kitov Pharmaceuticals Holdings Ltd. TyrNovo...
BioCentury | Jul 25, 2016
Clinical News

Celecoxib/amlodipine besylate: Additional Phase III data

...of celecoxib/amlodipine besylate in parallel with an NDA submission for the product at year end. Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jul 11, 2016
Finance

Ground up

...Date Raised Post-$ 6/30 mcap % chg Tesaro Inc. (NASDAQ:TSRO) 6/30/16 $433.1 $4,146.6 $4,302.7 4% Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jul 11, 2016
Finance

Rethinking risk

...lymphoma (DLBCL), primary mediastinal B cell lymphoma (PMBCL) and transformed follicular lymphoma Submit BLA YE16 Kitov Pharmaceuticals Holdings Ltd....
BioCentury | Jul 11, 2016
Financial News

Kitov Pharmaceuticals completes follow-on

Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV), Tel Aviv, Israel Business: Cardiovascular, Neurology Date completed: 2016-06-29 Type: Follow-on Raised: $12 million Units: 2.4 million Price: $3.40 (unit) Shares after offering: 6.5 million Underwriters: H.C. Wainwright;...
Items per page:
1 - 10 of 20